Trial
NCT01565395
Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
Merz Pharmaceuticals
Condition
Parkinson Disease
Intervention
Incobotulinum Toxin A
Why stopped
Could not recruit ALS participants, hence ALS arm discontinued
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-07